Aktiesnakken — Juli 2012
-
vi forhandler lige nu med en ny udbyder af fundamental data
-
ikke nødvendigvis, men thompson reuters har svært ved at levere til tiden og nogle er helt skæve
-
det er altid det sikreste
-
men vi går typisk dem selv igennem efter hvert regnskab
-
men ret irriterende når vi betaler for at få fundamentals fra Thompson.
-
ja det er rigeligt
men de har jo også haft de problemer med fabrikken -
Zealand Pharma oppe 8%, nyheder?
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind